MedPath

The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?

Not Applicable
Conditions
Anastomotic Leakage
Registration Number
NCT01696682
Lead Sponsor
Fudan University
Brief Summary

The study hypothesized that a narrow gastric conduit(less than 3cm in width) would minimize anastomotic leakage following minimally invasive esophagectomy. Therefore we raise this random-controlled research, and investigate the leakage ratio from different widths of gastric conduit formed during the operation.

Detailed Description

Patients underwent minimally invasive esophagectomy in Zhongshan Hospital of Fudan University will be enrolled and be assigned to wide or narrow gastric conduit group randomly. Intra-operative blood supply and vascular SaO2 will be observed during the operation, and the rate of anastomotic leakage, together with its clinical details will be recorded in the two groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Patients underwent minimally invasive esophagectomy(three-hole procedure)
  2. Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as T1-3N0M0 esophageal cancer after neo-adjuvant therapy
Exclusion Criteria
  1. With previous cancer history
  2. Severe Co-morbidity

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
The anastomotic leakage ratethe anastomotic leakage of participants will be followed for the duration of hospital stay, an expected average of 2 weeks

The anastomotic leakage is a severe complication following minimally invasive esophagectomy. The definition of anastomotic leakage is determined as per the STS (SOCIETY OF THORACIC SURGEONS) database.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Thoracic Surgery, Zhongshan Hospital of Fudan University

🇨🇳

Shanghai, China

Division of Thoracic Surgery, Zhongshan Hospital of Fudan University
🇨🇳Shanghai, China
Yaxing Shen, MD
Contact
86-13661983366
shen.yaxing@zs-hospital.sh.cn
Hao Wang, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.